Navigation Links
Frontier Biventricular Stimulation Device

ProductsFrontier Biventricular Stimulation Device
Company St. Jude Medical, Inc.
Item Frontier Biventricular Stimulation Device
Features Triggered Modes
  • DDT mode (programmable for atrial-based [DDD] or ventricular-based [DDI] timing) helps to assure continuous synchronization with intrinsic plus stimulation-based heartbeats.

Negative AV/PV Hysteresis with Search

  • This feature automatically shortens the programmed AV/PV delay when a sensed ventricular event occurs during the AV/PV delay interval. This may provide hemodynamic benefits for those patients who may benefit from ventricular stimulation with a shorter than normal AV interval.

Auto Mode Switch

  • The auto mode switch (AMS) algorithm allows the device to switch from the DDD(R) to the DDI(R) mode in the presence of atrial tachyarrhythmias.

Rest Rate

  • The Frontier multi-site BV stimulation device includes the clinically proven Omnisense accelerometer sensor, and such automatic features as auto slope, auto threshold, Rest Rate (based on activity rather than a preset clock setting), and AutoIntrinsic Conduction Search (AICS).
  • The Rest Rate reduces the pacing rate below the Base Rate when the device senses that the patient has been inactive for more than 15-20 minutes.
  • This automatic feature can be used to provide a more comfortable and physiologic pacing rate during rest or inactivity and can help to prolong battery life.

Pre-Ventricular Atrial Blanking

  • Pre-VAB can be used to blank sensed far-field events from the devices atrial sensing.
  • This helps to ensure more accurate mode-switch behavior.
AMS Event and AMS Heart Rate Histograms
  • These histograms provide a graphical representation of events occurring during mode-switch episodes, and can be used to help analyze device behavior during periods of atrial tachyarrhythmias.
Description The Frontier device is a multi-site, implantable biventricular pacing device with one atrial and two ventricular ports for patients with chronic atrial fibrillation (AF) who have undergone an AV node ablation and who have NYHA Class II or III heart failure.
Info St. Jude Medical, Inc.
Customer Service: (800) 328-9634
Web site: http://www.sjm.com

Related medicine products :

1. Frontier
2. Frontier® CRT-P Biventricular Stimulation Device
3. Frontier CRT-P
4. Frontier® II CRT-P
5. BVS 5000 Biventricular Support System
6. InterStim Therapy -- Sacral Nerve Stimulation (SNS) for Urinary Control
7. Adrenocorticotropic Hormone Stimulation, 0 Minutes
8. Adrenocorticotropic Hormone Stimulation, 60 Minutes
9. Adrenocorticotropic Hormone Stimulation, 30 Minutes
10. GnRH Stimulation Test
11. LH/FSH (GNRH Timed Stimulation Test)
Alanine Aminotransferase (ALT) reagent is used for the quantitative determination of alanine aminotransferase (Glutamate pyruvate transaminase, SGPT) in human serum....
... Intended for the quantitative determination ... serum or plasma. Liquid buffer ... Phosphate tablets must be purchased ... method. Kinetic reaction. Wavelength: 340 ...
For the quantitative determination of total protein concentration in human serum....
Urea nitrogen (BUN) liquid reagent is used for the kinetic quantitative determination of Urea Nitrogen (BUN) in human serum used in routine examination and monitoring of therapy and relapses....
Medicine Products:
(Date:1/17/2017)... Houston, TX (PRWEB) , ... January 17, 2017 , ... ... they have earned the highest honor of Diamond Level in Zeltiq’s Crystal Rewards Program. ... been named part of this elite group of providers. , Produced by Zeltiq, ...
(Date:1/17/2017)... ... January 17, 2017 , ... Surgeons from New York’s ... care practitioners on the latest breakthroughs in the prevention, diagnosis and treatment of ... according to eye surgeon, Jeffrey Martin, MD, FACS, Chief Executive Officer of SightMD ...
(Date:1/17/2017)... ... January 17, 2017 , ... Neil H. Greco Insurance Agency, a northern ... throughout the region, is launching a charity drive to raise awareness of heart disease ... deadliest killer in America, and is responsible for 1 in every 4 deaths at ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... Livionex, Inc., ... results of a double blind clinical study for its dental gel that shows significant ... national brand of toothpaste containing triclosan. The study was conducted at the Beckman Laser ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... offices in Tyler, has announced the latest beneficiary of their thriving community involvement ... nonprofit organization dedicated to fulfilling the dreams of terminally ill patients. Donations to ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... 2017 Interpace Diagnostics Group, Inc., (NASDAQ: ... diagnostic tests and pathology services for evaluating risks of ... dated January 13, 2017 from the NASDAQ Listing Qualifications ... the requirement of the NASDAQ Stock Market to maintain ... The letter noted that for the last ...
(Date:1/17/2017)... and Markets has announced the addition of the "The Top 200 ... ... profiles the leading 200 manufacturers and distributors of molecular diagnostics products worldwide. ... States and Europe to ... Profile information for each company in The Top 200 Molecular Diagnostics Companies ...
(Date:1/17/2017)... 17, 2017 Catherine ... http://www.touchneurology.com/articles/tailored-temperature-management-neurocritical-care ...      (Logo: ... European Neurological Review , ... Amey reports that despite standard care, temperatures ...
Breaking Medicine Technology: